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Available online at www.sciencedirect.comThe role of the mammalian intestinal microbiota in health and
disease of the host has long been recognized and extensively
studied. Largely, these studies have focused on the bacterial
component of the microbiota. However, recent technological
advances have shed new light on the microbiome at distinct
anatomical locations and uncovered the role of additional
microbial symbionts, including the virome and endogenous
retroelements. Together, they have revealed interactions more
intricate than previously recognized. Here, we review recent
advances in our knowledge of this collective microbiome and
the interactions with the immune system of their host.
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Introduction
For their energy and building blocks, all living organisms
depend on their environment, which includes other living
organisms. This type of biological interaction between
organisms has led to diverse and often surprising relation-
ships. Predation and parasitism are perhaps the most
easily recognizable types. Parasitism in particular is also
the most likely driving force for the evolution of immu-
nity. Evident even today is the evolutionary struggle
between parasites and their hosts’ immune systems. This
can lead to the extinction of either the parasite or the host,
but when a certain degree of mutual adaptation has taken
place, it can also lead to equilibrium where invasion or
colonization of the host by the parasite results in accep-
table levels of pathology. Indeed, almost all humans are
Open access under CC BY license.Current Opinion in Immunology 2013, 25:456–462 infected by one or more persistent viruses and the origin
of certain exclusively human pathogens can be traced
back to the expansion of modern humans. The apparent
lack of acute host pathology induced by many coevolved
infectious microbes can quickly change to severe disease
when the host’s immune system is weakened. The poten-
tial severity of these opportunistic infections highlights
the constant threat posed by pathogens seemingly not
causing disease in healthy individuals.
As well as interacting with a range of pathogens, living
organisms have also evolved important commensalistic
and even truly mutualistic relationships. Mucosal surfaces
in vertebrates are colonized by complex communities of
microbes, collectively referred to as the microbiota, many
of which exhibit species preference and are well-tolerated
by their host [1]. The microbiome, the combined genetic
composition of all these symbionts, greatly outnumbers
the host’s genome and contains information for metabolic
processes that complement those of the host. It is likely
that mutual metabolic benefit was the evolutionary driver
of this interaction. The majority of studies have focused
on the bacterial component of the microbiota. However,
characterization of the fungal (mycobiome) and viral
(virome) components and their function is under way
[2,3]. Despite the large extent of coadaptation, the
microbiota is not always harmless to the host. Some of
these symbionts can exploit weaknesses in host defenses
to become pathobionts, otherwise innocuous microbes
that invade the host and cause pathology [4].
For one class of microbes, symbiosis with the host has
taken an additional dimension. Nearly half of the human
genome is composed of retrotransposons, including
endogenous retroviruses (ERVs), relics of ancestral retro-
viral infection of the germ-line that have persisted over
long evolutionary periods or even amplified their copies
[5]. Although few of these retrotransposable elements,
which make up the vast majority of the eukaryotic mobi-
lome, are still active in certain host species or even co-
opted in several physiological processes, the majority are
restrained by transcriptional silencing and/or inactivating
mutations [5]. Whether the immune system participates
in the control of the mobilome has been less clear.
Here, we review recent studies that have shed light on the
balanced interaction between all the multitudes of
microbial species, which we will collectively refer to as
the microbiome, and the immune system of their mam-
malian host.www.sciencedirect.com
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Evidence for extensive interaction between the immune
system and this diverse set of microbes is found in three
key phenomena. Firstly, detectable innate and adaptive
immune reactivity to products of the microbiome both in
health and disease indicates exposure. Secondly, changes
in microbiota composition or activity in genetic immune
deficiencies argue that immunity is involved in micro-
biome control. Thirdly, altered immune system devel-
opment and response to unrelated antigens, including
self-antigens, suggest immune modulation by the micro-
biome.
Immune reactivity against the microbiome
Like pathogens, the microbiota have the potential to
trigger both innate and adaptive immune responses. As
innate responses lack the specificity and memory that
characterize adaptive responses, it is often difficult to
discern whether innate responses to shared molecular
patterns have been triggered by the microbiota or patho-
gens. Therefore, the best evidence for immune reactivity
to the microbiome has come from the study of adaptive
immune responses.
The presence of large numbers of CD4+ T cells in the
healthy intestinal tract has been seen as evidence of
immune alertness to invasion by intestinal microbes.
However, the T cell response must also maintain toler-
ance of intestinal microbiota and avoid pathologies associ-
ated with tolerance breakdown, a suspected cause of
inflammatory bowel disease. This is thought to be
achieved by a combination of both immunological ignor-
ance due to microbiota sequestration in the gut lumen
and active immunological tolerance, in which regulatory
T (Treg) cells play an important role [6].
Prevention of systemic immune activation presents a key
feature of immunological tolerance towards the intestinal
microbiota. One mechanism for maintaining such toler-
ance is mucosal immune system compartmentalization, i.e.
restriction of the immune response to the mucosal site in
the intestine. New evidence extends this concept to an
active role of the commensal microbiota by regulating the
migration of bacteria-loaded CX3CR1-expressing mono-
nuclear phagocytes from the lumen to the mesenteric
lymph nodes, thereby aiding tolerance towards commensal
microbes [7].
In addition to compartmentalization of the mucosal
immune system, commensal-driven induction of anti-
inflammatory T lymphocyte subsets promotes a tolerogenic
state. Several new studies have reinforced the idea of Treg
cell induction by gut microbiota. Treg cell numbers in the
murine intestine correlated with colonization by Clostridia
clusters IV and XIVa [8]. Similarly, colonization of mice
with the limited diversity altered Schaedler flora,
which includes Clostridium clostridioforme but not Bacteroideswww.sciencedirect.com fragilis, was sufficient to cause the accumulation of intestinal
Treg cells [9]. Clostridia colonization-induced intestinal
Treg cells displayed the phenotypic characteristics of per-
ipherally induced Treg (iTreg) cells, suggestive of local
differentiation in the intestine, likely due to elevated TGF-
b levels induced by this particular bacterial cluster [8].
However, it is also possible that iTreg cells were induced
in response to particular Clostridia antigens. Further evi-
dence of a Treg cell response to intestinal microbiota was
also provided by sequencing and cloning of intestinal Treg
cell T cell receptors (TCRs) [10]. This study supported the
idea of iTreg induction in response to bacterial antigens,
including from a previously uncharacterized Clostridiales
species [10].
Direct detection of the microbiota by Treg cells can also
be mediated by receptors other than the TCR. Toll-like
receptor (TLR) 2 recognition of Bacteroides fragilis poly-
saccharide A (PSA) has now been shown to induce IL-10
production in murine Treg cells and modulate intestinal
inflammation [11]. Moreover, regulatory responses
induced by PSA seem to be required for the suppression
of conventional T helper (Th) cell responses to intestinal
bacteria [11].
Treg cell-mediated suppression could be a possible expla-
nation for the apparent lack of microbiota-specific patho-
genic Th cell responses in the steady-state. Spontaneous
Th1 or Th17 cell responses against the bacterial species
associated with Treg cell induction have not been
observed, contrasting the established role of the certain
microbiota species in the development especially of Th17
cells. It is, therefore, possible that microbiota-dependent
Th17 cells are reactive with as yet unidentified bacteria or
that their specificity is not restricted to the microbiota.
Supporting the latter possibility, the use of hen egg lyso-
zyme-specific TCR-transgenic T cells, which do not react
with microbial antigens, did not prevent the development
of intestinal Th17 cells [12]. Moreover, the use of Clos-
tridium cluster XIVa flagellin-specific TCR-transgenic T
cells suggested that specificity for microbiota is not suffi-
cient for induction of Th1 or Th17 cell responses due to
immunological ignorance in the steady-state [13]. How-
ever, flagellin-specific Th1 and Th17 cell responses were
indeed induced if ignorance was broken by intestinal
chemical injury and infection, respectively [13].
These new studies on T cell reactivity to microbiota
complement several prior studies that have documented
antibody reactivity to the same antigenic universe
(reviewed in [14]). Induction of microbiota-specific anti-
body responses, and of the IgA class in particular have
been observed in numerous experimental systems [15].
Similarly, both T cell and antibody responses to antigens
encoded by endogenous retroviruses are readily detected
during chronic diseases, including inflammation, infec-
tion and cancer [16]. These studies together illustrate thatCurrent Opinion in Immunology 2013, 25:456–462
458 Host pathogensthe vast number of potential antigens encoded by the
microbiome, including the mobilome, can elicit specific
immune responses. However, whether these adaptive
immune responses will be beneficial or harmful for the
host will depend on the context in which these responses
are elicited.
Immune-mediated control of the microbiome
The best evidence that host immune responses partici-
pate in establishing the mutualistic balance with the
microbiota derives from studies of immune deficiencies
where this balance is disrupted. Adding to a long list of
innate immune sensors and mediators regulating symbio-
sis with intestinal bacteria, genetic deficiency in inflam-
masome activation resulted in dysbiosis, a change in
intestinal bacteria composition causing disease transmis-
sible to immune-sufficient mice [17,18]. Given familial
transmission of the microbiota, careful studies with TLR-
deficient mouse colonies have also shown that changes in
microbiota composition may arise from housing con-
ditions rather than from gene function alteration [19].
Furthermore, changes in microbiota composition may
also result from intestinal immune responses to unrelated
infections or chemical injury [20].
Perhaps clearer is the contribution of innate lymphoid
cells (ILCs), a collection of effector lymphocytes lacking
antigen receptors, to establishing equilibrium with the
intestinal microbiota. The balance of IFN-g and IL-17A
production in ILCs, determined by T-bet expression, was
recently found critical in preventing dysbiosis of Helico-
bacter typhlonius [21]. Furthermore, IL-22 production by
ILCs was also found necessary to contain bacteria of the
Alcaligenes species in lymphoid tissue and prevent
systemic dissemination [22].
Innate immune responses to the microbiota, together
with physical barriers, may prevent Th cell responses
against microbiota antigens. The contribution of Th cells
to the control of microbiota has remained unclear. A large
proportion of the microbiota-specific IgA response is
thought to be Th cell-independent. IgA-producing B
cells have also been shown to acquire additional
innate-like production of TNF-a and iNOS, which were
required for the diversification of the microbiota and
defence against Citrobacter rodentium [23]. The require-
ments for an effective IgA response are also better defined
now. Preclusion of somatic hypermutation, but not Ig
class switching, in a novel mutant of the activation-
induced cytidine deaminase (AID) has highlighted an
important role for affinity maturation in effective IgA
responses [24]. High-affinity IgA responses to the micro-
biota were found to rely on limited availability of follicu-
lar helper (Tfh) cell help, which in turn was regulated by
programmed cell death-1 (PD-1) signals [25]. The origin
of Tfh cells in the Peyer’s patches that are required for
basal and Cholera toxin-induced IgA responses seems toCurrent Opinion in Immunology 2013, 25:456–462 go through a Th17 program, illustrating the contribution
of Th17 cells to the intestinal IgA response. [26].
Consistent with sharing microbiota-specificity [10], iTreg
cells were also required for establishing the balance
between intestinal bacterial communities [27]. More-
over, Treg cells were also necessary for mutualistic colo-
nization by B. fragilis [11]. Collectively, these studies
further confirm that at least some of the microbiota-
induced adaptive immune responses are not merely a
by-product of antigenic exposure following intestinal
injury or infection, but critical players in appropriate
control of intestinal bacteria.
In contrast to the wealth of data supporting immune control
of the intestinal microbiota, endogenous retroelements are
thought to be controlled primarily through mutation and
gene repression. Two new studies now provide evidence
that both innate and adaptive immune responses actively
participate in maintaining the non-infectious state of
endogenous retroviruses [28,29]. Deficiency in the
innate sensor TLR7 or associate signaling molecules, or
lack of antibodies has now been shown to allow for the
establishment of fully-infectious pathogenic murine leu-
kemia viruses as a result of recombination between repli-
cation-defective endogenous proviruses [28,29].
Immune modulation by the microbiome
The bidirectional nature of interaction between particular
microbial species and the immune response against them
is now clearer. However, interaction of the immune
system with one microbe can also affect immune reactiv-
ity to another. Accumulating evidence suggests that the
microbiome can profoundly shape the host’s broad
immune responsiveness, with implications for immunity
to infection, immune pathology or autoimmunity.
When incompletely controlled by the antibody response,
intestinal microbiota have the capacity to modulate intes-
tinal epithelial cell function and promote transcriptional
networks related to immunity at the expense of metab-
olism [30]. Microbiota-derived signals prime inflamma-
some activation [31] and macrophage responsiveness to
infectious pathogens and confer ability to produce inter-
ferons [32,33], all contributing to antiviral immunity. In
addition, the microbiota can instruct development or
effector function of various innate cell types, including
NK and NK T cells, ILCs and basophils, affecting both
pathologic (e.g. colitis, asthma) or protective responses
(e.g. protection against intestinal infection) [33–37].
Modulation of myeloid cell function by the microbiota
will inevitably extend to modulation of T cell responses,
which rely on myeloid cells for antigen recognition and
effector polarization. Both basal Th17 effector cell de-
velopment and Th1 cell responses to Leishmania major
infection were affected by the local microbiota in the skinwww.sciencedirect.com
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such as autoimmune encephalomyelitis (EAE) and arthri-
tis was also influenced by microbiota-derived signals
[39,40]. In addition to modulating Th cell polarization,
the microbiome can also affect the TCR repertoire that is
available to respond to pathogenic infection. This is
particularly relevant to the vast number of potential
epitopes encoded by commensal bacteria and also
endogenous retroviruses. Indeed, one such epitope from
an endogenous retrovirus was recently shown to promote
high avidity CD4+ T cell responses to exogenous retro-
viral infection, by mediating negative selection of low
avidity, but highly crossreactive clones [41].
By inducing the development of at least certain iTreg cells,
the intestinal microbiota could also indirectly affect
immune regulation in many different settings. Specific
deletion of the iTreg cell population, which likely contains
the microbiota-specific Treg cells [10], led to Th2 cell-
mediated inflammation in mucosal sites [27], implicating
iTreg cells in mucosal responses to unrelated allergens.
However, iTreg cells, and by extension microbiota-
induced iTreg cells, were not required for protection
against EAE [27]. Furthermore, Treg cell-mediated sup-
pression of fatal systemic inflammatory disease is indepen-
dent of the microbiota [42], and systemic immune
activation caused by Treg cell insufficiency is distinct from
intestinal bacterial-driven inflammation [43].
Complex microbial interactions
It is now becoming clear that by altering immune cell
development, reactivity or function, symbionts may
indirectly affect immune control of each other or of
infectious pathogens. In addition to this type of inter-
action via immune modulation, it is also possible that the
vast array of species that make up the microbiome can
interact more directly.
Extending previous findings (reviewed in [44]), the
further definition of a limited number of enterotypes
[45], balanced host–microbial symbiotic states, might
suggest the existence of distinct equilibrium states be-
tween interacting microbes. Enterotypes increase in
diversity and stability with age and can also resist small
external disturbances with a tendency to return to their
original state [1]. However, substantial effects in micro-
biota diversity induced by long-term dietary changes,
medical intervention (e.g. antibiotic treatment) or intes-
tinal inflammation can also shift enterotypes to distinct
but equally stable states. The particular enterotype estab-
lished during development and its degree of stability or
cumulative change in response to environmental factors,
such as diet and antibiotic treatment, may also determine
susceptibility to disease [1]. For example, diets rich in
saturated fat can induce expansion of Bilophila wads-
worthia, which becomes a pathobiont in genetically
susceptible hosts [46]. However, dietary compounds orwww.sciencedirect.com derivatives, such as aromatic hydrocarbons can also affect
intestinal immunity directly, with secondary effects on
control of bacteria [47,48].
The potential of otherwise innocuous commensal bac-
teria to cause or contribute to inflammatory pathology in
hosts with congenital or infection-induced immunodefi-
ciency has been recognized [4]. It is now clear, however,
that inflammation caused by intestinal immune responses
to unrelated infections or chemical injury can conversely
change the microbiota composition, complicating associ-
ation studies [20]. Indeed, it has been shown that nitrate,
a by-product of the inflammatory response, aids coloniza-
tion of Escherichia coli and potentially other members of
the Enterobacteriaceae and replacement of the resident
obligate anaerobic microbiota [49]. Furthermore, recent
evidence from simian immunodeficiency virus (SIV)-
infected rhesus monkeys suggests that expansion of the
enteric virome, instead of previously incriminated intes-
tinal bacteria, drives intestinal pathology and systemic
immune activation [2]. Epithelial damage caused by
these enteric viruses may in turn facilitate secondary
translocation of intestinal bacteria or their products.
There is also evidence that intestinal bacteria-derived
lipopolysaccharide (LPS) can bind virions and promote
infection by poliovirus and mouse mammary tumor virus
(MMTV) [50,51].
The effect of immune system stimulation or suppression
by commensals or pathogens might extend beyond the
control of other microbes. The spontaneous establish-
ment of pathogenic retroviruses from ERV precursors in
mice with distinct immune deficiencies was recently
found to depend on housing conditions that affect the
composition of the microbiota and was not observed in
germ-free mice [28]. The consequence for the host of
potential ERV activation by uncontrolled commensals or
pathogens will require further investigation.
Concluding remarks
Throughout the past decade, the interest for the intestinal
microbiota and its relevance to human health has increased
dramatically. As new insights into microbiome–host inter-
actions begin to emerge, it becomes clear that the poise
between the microbiome and host regarding health and
disease is a precarious one, relying heavily on a finely tuned
balance of immune tolerance and response (Figure 1). Dis-
ruption of these complex mechanisms can have severe
consequences for host health. Studies assessing the human
virome revealed a high temporal stability but marked inter-
personal variation suggesting a steady symbiosis between an
individual’s microbiota and viruses [52]. Whether and how
these new microbial components impact on immune func-
tion and disease phenotypes remains to be assessed.
Albeit extensively studied, microbial effects on host physi-
ology and the mechanisms involved in the host–microbiomeCurrent Opinion in Immunology 2013, 25:456–462
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Hypothetical integrative model of interaction between the collective microbiome and the immune system of the host. This balance also depends on
additional intrinsic (e.g. host genetics) and environmental factors (e.g. use of antibiotics), acting on either the immune system or on the microbiome
directly, but their effect is not integrated in this model for simplicity. In a healthy state (left), transcriptionally controlled ERVs and a balanced
microbiome may contribute to immune system development, regulation and tuning of reactivity. Successfully cleared or controlled infections with
pathogenic microbes also generate immunological memory. The overall effect is robust immunity with minimal pathology. Perturbations of this fine
balance (right) may result from and also give rise to uncontrolled growth of infections pathogens and associated pathology, infection by otherwise
innocuous microbes, dysbiosis of the intestinal microbiota, generalized immune activation and ERV reactivation, all reducing immune competence.
Green and red arrows indicate positive and negative effects, respectively.interaction still pose many challenges. Comprehensive
understanding of the composition and function of the
‘healthy’ gut microbiome may provide a valuable tool for
the design of innovative nutritional and probiotic strat-
egies. Indeed, new studies increasingly exploit the
benefit of systemic immune modulation via the mucosal
immune system by probiotics with positive outcomes.
Symbiotic treatment of SIV-infected macaques with the
commensal Lactobacillus plantarum induced SIV-specific
tolerance via induction of a subset of regulatory CD8+ T
cells [53], while administration of a probiotic/prebiotic
supplement increased the frequency and functionally of
intestinal antigen-presenting cells, CD4+ T cells and
mitigated local inflammation and damage [54]. These
and other studies provide a promising outlook to the
possibility of microbiota-targeted therapy.Current Opinion in Immunology 2013, 25:456–462 Acknowledgements
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